Skip Navigation
Close Btn

Kevin R. Brenner

Special Counsel | Global Investigations & Risk Advisory | Regulatory & Compliance | Employment Risk & Workplace Investigations

Kevin R. Brenner is Special Counsel at Global Link Law, where he leads the firm’s Global Investigations & Risk Advisory and Regulatory & Compliance and Employment Risk & Workplace Investigations practices. A former federal prosecutor with more than two decades of courtroom, investigative, and advisory experience, Kevin helps healthcare and multinational organizations manage enforcement risk, respond to government scrutiny, and build compliance programs that operate effectively across borders.

Kevin leads complex cross-border investigations involving fraud, corruption, bribery, third-party misconduct, and other high-risk conduct across the United States, Europe, Asia, and Latin America. He advises clients in DOJ, SEC, and international regulatory matters, helping senior leadership assess exposure, preserve credibility, and execute a disciplined response under pressure.

His compliance work focuses on practical, defensible risk frameworks for organizations operating in high-risk and highly regulated markets. Kevin advises on FCPA and anti-corruption compliance, third-party risk involving agents, intermediaries, and international partners, healthcare fraud, waste, and abuse detection and response, and litigation strategy for high-stakes investigations and enforcement matters.

Kevin also advises companies on employment-related risk issues that intersect with investigations, compliance, and executive decision-making. His work includes employee relations matters, workplace investigations, separation agreements, severance terms, sensitive terminations involving protected classes or potential retaliation claims, and the design of employee relations interview protocols, policies, and procedures.

In addition to private practice, Kevin served as a federal prosecutor, where he developed the investigative judgment, courtroom discipline, and enforcement perspective that now guide his client work. He brings that same precision to every engagement, translating complex legal and regulatory risk into clear strategy, practical controls, and defensible outcomes.

Kevin brenner headshot

Working with Kevin R. Brenner gives clients a rare combination: the judgment of a former federal prosecutor, the discipline of an experienced investigations lawyer, and the practical perspective of a compliance advisor who understands how organizations actually operate.

Kevin has spent more than two decades leading high-stakes matters involving fraud, corruption, regulatory scrutiny, and enterprise risk. He brings prosecutorial precision to complex investigations and turns legal exposure into clear, actionable strategy for healthcare companies and multinational organizations operating in demanding markets.

Clients work with Kevin because he brings:

  • Prosecutorial Judgment: As a former federal prosecutor, Kevin understands how enforcement authorities evaluate evidence, assess credibility, and build cases. He uses that perspective to help clients respond with discipline, accuracy, and control.
  • Cross-Border Investigations Experience: Kevin has led complex investigations across the United States, Europe, Asia, the Middle East, and Latin America, helping organizations navigate overlapping legal regimes, cultural differences, and fast-moving regulatory pressure.
  • Practical Compliance Leadership: Kevin designs compliance and risk frameworks that are built for real-world operations, including FCPA and anti-corruption controls, third-party risk management, healthcare fraud, waste, and abuse response, and enterprise-level reporting structures.

Kevin’s approach is practical, defensible, and mission-focused. He helps clients protect the organization, preserve credibility with regulators and stakeholders, and make confident decisions when the stakes are high.

  • Global Link Law (April 2026 – Present): Special Counsel leading the firm’s Global Investigations & Risk Advisory and Regulatory & Compliance and Employment Risk & Workplace Investigations practice. Advises healthcare and multinational organizations on cross-border investigations, FCPA compliance, third-party risk, fraud waste and abuse (FWA), and complex regulatory matters, employee relations, workplace investigations, separation agreements, severance terms, sensitive terminations, retaliation-risk assessments, and the design of practical employee relations interview protocols, policies, and procedures.
  • Capital RX (August 2024 – April 2026):
    • Managed PBM/PBA regulatory affairs, licensing, and litigation/dispute resolution.
    • Led responses to external legal and regulatory inquiries, market conduct exams, and client audits, ensuring compliance with legal requirements.
    • Supported provider network team in contract negotiations; primary legal support for pharmacy contracting.
    • Served as legal advisor to SIU on FWA initiatives, shaping investigative approach and establishing regulatory alignment.
    • Guided HR and business leaders on employee relations, workplace investigations, separation agreements, severance terms, sensitive terminations, retaliation-risk assessments, and employment compliance practices designed to reduce organizational risk.
  • Cigna Healthcare / Express Scripts:
    • Led a team in identifying and remediating legal and regulatory risks across the enterprise, collaborating with senior leaders to mitigate complex issues.
    • Managed litigation and responses to state and federal regulatory inquiries; led investigations into matters involving PBM activities, healthcare fraud, SOX compliance, and public corruption.
    • Successfully increased ethics help line reporting and reduced anonymity rates through driving ethics and compliance awareness activities.
  • Enviri:
    • Managed a global team of 25 professionals across multiple continents, overseeing internal investigations and briefings to senior management.
    • Led an 18-month investigation into FCPA issues resulting in disclosures to regulatory bodies.
    • Identified and remediated large-scale fraud schemes, saving the company millions in lost revenue.
    • Built and operationalized compliance policies and procedures across the enterprise, driving measurable improvements in ethics reporting, including increased hotline usage and reduced anonymity.
  • Federal Prosecutor (U.S. Department of Justice): Nearly two decades of federal prosecution experience. Led high-stakes investigations and prosecutions involving fraud, corruption, and organized criminal enterprise. Developed deep expertise in evidence gathering, witness strategy, and courtroom litigation that now informs every client advisory engagement.
  • Private Practice — Complex Litigation, Regulatory Enforcement & Investigations: Represented multinational corporations and healthcare organizations in complex litigation, government investigations, regulatory enforcement matters, and cross-border compliance challenges across the U.S., Europe, Asia, and Latin America.

Practice Expertise

  • FCPA & Anti-Corruption Compliance: Program design, implementation, internal controls, third-party oversight, and enforcement defense.
  • Global Investigations & Enforcement Strategy: High-stakes, cross-border investigations involving fraud, corruption, bribery, conflicts of interest, and other misconduct; government inquiries and regulatory enforcement matters across the U.S., Europe, Asia, the Middle East, and Latin America.
  • Third-Party Risk Management: Risk assessment, diligence, monitoring, and controls for agents, intermediaries, distributors, international partners, and supply chain relationships.
  • Fraud, Waste & Abuse (FWA): Detection, response, remediation, and control design for healthcare organizations and other regulated businesses.
  • Enterprise Risk Frameworks: Practical, defensible compliance programs built for multinational organizations operating in high-risk and highly regulated markets.
  • Litigation: Extensive civil litigation experience, including first-chair trial work and managing outside counsel for a Fortune 10 company.

 

Speaking Engagements & Published Works

  • Contributed insights on cross-border investigations, FCPA enforcement trends, and global compliance strategy at industry conferences and legal forums
  • Authored and co-authored materials on enterprise risk management and regulatory compliance best practices for multinational organizations

 

Bar Admissions

  • Admitted in the State of Illinois, Commonwealth of Pennsylvania, Third and Seventh Circuit Courts of Appeals, Eastern District of Pennsylvania and Northern District of Illinois

Kevin R. Brenner is a leading global investigations and regulatory compliance attorney with deep expertise in cross-border enforcement, enterprise risk management, and fraud prevention for healthcare and multinational organizations. His practice centers on three interconnected pillars:

  • Global Investigations & Enforcement Defense: Kevin leads complex investigations involving fraud, corruption, bribery, and internal misconduct. Drawing on his experience as a former federal prosecutor, he helps clients respond to government inquiries, DOJ and SEC matters, and international regulatory scrutiny with clear strategy, disciplined execution, and defensible outcomes.
  • Regulatory Compliance & Risk Frameworks: Kevin designs and implements practical, enterprise-wide compliance programs for organizations operating in high-risk, highly regulated markets. His work includes FCPA and anti-bribery controls, third-party risk management, internal reporting and escalation systems, and industry-specific compliance frameworks across North America, Europe, Asia, and Latin America.
  • Healthcare Fraud, Waste & Abuse (FWA): Kevin advises health plans, health systems, providers, and healthcare-adjacent organizations on FWA prevention, detection, response, and remediation. He helps clients reduce financial exposure, strengthen controls, and maintain operational integrity in a complex regulatory environment.
  • Employment Risk & Workplace Investigations: Advises companies on employee relations, workplace investigations, separation agreements, severance terms, sensitive terminations, retaliation-risk assessments, and the design of practical employee relations interview protocols, policies, and procedures.

Learn more about how Kevin leads Global Link Law’s FCPA & Anti-Corruption and Investigations practices.

Bar Admissions:

  • Admitted in the State of Illinois, Commonwealth of Pennsylvania, Third and Seventh Circuit Courts of Appeals, Eastern District of Pennsylvania and Northern District of Illinois

Professional Memberships & Affiliations:

  • Member, American Bar Association — Section of International Law
  • Member, Association of Certified Fraud Examiners (ACFE)
  • Member, Society of Corporate Compliance and Ethics (SCCE)
  • Member, American Health Law Association (AHLA)

Education:

  • University of Wisconsin-Madison, Bachelor of Arts, Political Science and Government
  • Chicago-Kent College of Law
    • Dean’s List
    • Executive Board Vice President, the National Moot Court Honor Society
    • Winner, Charles Evans Hughes Moot Court Competition
    • Finalist, National Moot Court Competition

Strategic Legal Counsel for Healthcare & Health Technology

Your organization faces legal and regulatory complexity that demands more than outside counsel — it demands a partner who has sat on your side of the table.

From government investigations and FCPA matters to healthcare M&A and payer contracting, we’ve handled it from the inside and from the courtroom.

Whether you need fractional leadership, transactional support, or a defensible compliance framework, we deliver counsel built around what the business actually needs. What sets us apart is real-world in-house experience — our partners have served in senior legal roles within large and publicly traded companies, giving them a direct understanding of what business leaders and boards actually need from legal counsel.

Book a discovery call now

Navigate Complex Investigations & Compliance Challenges With Confidence

Issue #4 — Wells Fargo and the Number That Ate the Bank Read More

Issue #4 — Wells Fargo and the Number That Ate the Bank

By Kevin Brenner | Friday, June 12, 2026  Not Good is not an indictment of the companies it…

Issue #3 — Theranos: The Board That Was Built Not To Ask Read More

Issue #3 — Theranos: The Board That Was Built Not To Ask

Theranos had one of the most prestigious boards in America, and one of the least effective. A study of how the board’s missing oversight enabled the fraud, and what it teaches about building boards that verify rather than vouch.

The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook Read More

The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook

By: Daniel Santos, Special Counsel | May 29, 2026 Daniel Santos Helping Healthtech CEOs &…

Not Good: Bad Acts, BIG Costs   Issue #2 — Dieselgate: Ten Monkeys, One Beetle, and Cartoons Read More

Not Good: Bad Acts, BIG Costs Issue #2 — Dieselgate: Ten Monkeys, One Beetle, and Cartoons

In Issue #2 of Not Good, Kevin Brenner examines Dieselgate — how Volkswagen’s defeat-device software, an industry-funded monkey exhaust study, and years of concealment from regulators produced over $25 billion in penalties, multiple prison sentences, and a lasting lesson in what happens when compliance risk becomes personal risk.

The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?” Read More

The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”

Two companies, same AI tools, totally different risk profiles. Daniel Santos on the new board question — “What’s our exposure to AI-driven misconduct?” — and why AI accountability, not technology, decides whether your governance holds up under scrutiny.

Red Flag: The Vendor Requested Far More PHI Than the Service Required Read More

Red Flag: The Vendor Requested Far More PHI Than the Service Required

A vendor deal that looked routine — clean MSA, sensible pricing, BAA already in place — almost moved forward in minutes. Then the SOW revealed a PHI request far beyond what was actually needed. Robyn D. Marino on why HIPAA compliance doesn’t stop at the BAA, and how SOW-level review changes the risk calculus on healthcare vendor agreements.

“When home.” How a two-word email subject line became part of a $650 million federal case. Read More

“When home.” How a two-word email subject line became part of a $650 million federal case.

By Kevin Brenner | Friday, May 22, 2026 Not Good is not an indictment of…

Do we still need to care about the FCPA? Read More

Do we still need to care about the FCPA?

By: Kevin Brenner, Esquire I’m hearing a surprising version of the same question from clients…